hydralazine has been researched along with Maxillary Neoplasms in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Maxillary Neoplasms: Cancer or tumors of the MAXILLA or upper jaw.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fried, R | 1 |
| Steinherz, LJ | 1 |
| Levin, AR | 1 |
| Linday, L | 1 |
| Tan, CT | 1 |
| Miller, D | 1 |
1 other study available for hydralazine and Maxillary Neoplasms
| Article | Year |
|---|---|
Use of hydralazine for intractable cardiac failure in childhood.
Topics: Antineoplastic Agents; Child; Chronic Disease; Female; Heart Failure; Humans; Hydralazine; Maxillary | 1980 |